Compound information
- Natural Products
- ZC3060305
- Molecular Formula
- C20H30O3
- Molecular Weight
- 318.21949482 g/mol
- Structure
-
- IUPAC Name
- (5Z,8Z,11E,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid
- InChI
- InChI=1S/C20H30O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-5,8-11,14,17H,2-3,6-7,12-13,15-16,18H2,1H3,(H,22,23)/b5-4-,10-8-,11-9+,17-14+
- InChI Key
- YGJTUEISKATQSM-PMCVYWRXSA-N
- SMILES
- CCCCCC(=O)/C=C/C=C/C/C=C\C/C=C\CCCC(=O)O
- Source
- ZINC000013516736
Warheads
- Michael Acceptor
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 23 | Ring Count | 0 |
| Heteroatom Count | 3 | Rotatable Bond Count | 14 |
| Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 54.37 Å2 | LogP | 4.231 |
| LogS | -4.78 | LogD | 3.057 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.023 | Pgp substrate | 0.03 |
| HIA | 0.968 | F20 % | 0.98 |
| F30 % | 0.071 | Caco-2 | -4.753 |
| MDCK | -5.617 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.033 | PPB | 97.497 |
| VD | 0.402 | Fu | 2.331 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.026 | CYP1A2 substrate | 0.361 |
| CYP2A6 substrate | 0.439 | CYP2B6 substrate | 0.351 |
| CYP2C19 inhibitor | 0.047 | CYP2C19 substrate | 0.375 |
| CYP2C8 substrate | 0.558 | CYP2C9 inhibitor | 0.38 |
| CYP2C9 substrate | 0.211 | CYP2D6 inhibitor | 0.352 |
| CYP2D6 substrate | 0.232 | CYP2E1 substrate | 0.227 |
| CYP3A4 inhibitor | 0.036 | CYP3A4 substrate | 0.065 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.989 | CL | 6.011 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.726 | Hepatotoxicity | 0.995 |
| Mutagenicity | 0.963 | Rat Oral Acute Toxicity | 0.008 |
| FDAMDD | 0.449 | Skin Sensitization | 0.994 |
| Carcinogenicity | 0.562 | Eye Corrosion | 0.043 |
| Eye Irritation | 0.95 | Respiratory Toxicity | 0.372 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 1.353 | IGC50 | 4.267 |
| LC50FM | 4.517 | LC50DM | 5.714 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.119 | NR-AR-LBD | 0.337 |
| NR-AhR | 0.002 | NR-Aromatase | 0.041 |
| NR-ER | 0.223 | NR-ER-LBD | 0.333 |
| NR-PPAR-gamma | 0.831 | SR-ARE | 0.015 |
| SR-ATAD5 | 0.265 | SR-HSE | 0.558 |
| SR-MMP | 0.012 | SR-p53 | 0.17 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.